Faeth Therapeutics FTH
NASDAQ FTH
$32.00 -0.10 (-0.31%)
At close: Aug 21, 2026 · 4:00 PM EDT

Faeth Therapeutics (FTH) Net Equity Issued and Repurchased (2020 - 2026)

Faeth Therapeutics' (FTH) quarterly Net Equity Issued and Repurchased came in at $200.0 million in Q1 2026, up 19999900.0% on a QoQ basis from $1000.0 in Q4 2021.

Faeth Therapeutics (FTH) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

Faeth Therapeutics (FTH) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $200.0 million in Q1 2026.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $200.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200.0 million (up 20000000.0% YoY) and the FY2021 annual result came in at $23.5 million, down 9.95% from the prior year.
  • Net Equity Issued and Repurchased advanced to $200.0 million in Q1 2026, from $1000.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $200.0 million in Q1 2026 to a low of $200.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Faeth Therapeutics 179.31 Mn 179.31 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 200.00 Mn
Mar 31, 2026 200.00 Mn
Dec 31, 2021 1,000.00
Dec 31, 2021 1,000.00
Mar 31, 2021 23.49 Mn
Mar 31, 2021 23.49 Mn
Dec 31, 2020 10.90 Mn
Dec 31, 2020 10.90 Mn
Sep 30, 2020 8.50 Mn
Sep 30, 2020 8.50 Mn
Mar 31, 2020 10.57 Mn
Mar 31, 2020 10.57 Mn